Cefoperazone : An Analysis of Results in the Pediatric Population from a Post-marketing Surveillance Study in Hospitalized Patients

Indian Journal of Pediatrics

Volumn 65, Issue 1, 1998, Pages 89-98

  Mukherjee, Shoibal ^a  

^a PFIZER INC   (United States)

Author keywords

Brain abscess; Cefoperazone; Pneumonia

Indexed keywords

CEFOPERAZONE;

ABDOMINAL ABSCESS; ADOLESCENT; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BRAIN ABSCESS; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOMYELITIS; PRESCHOOL CHILD; RASH; REVIEW; SCHOOL CHILD; SOFT TISSUE INFECTION; URINARY TRACT INFECTION; VOMITING;

ADOLESCENT; BACTERIAL INFECTIONS; CEFOPERAZONE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; HUMANS; INFANT; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PRODUCT SURVEILLANCE, POSTMARKETING; TREATMENT OUTCOME;

EID: 0141574618     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02849699     Document Type: Article

References (16)

1. Gordon AJ, Phyfferoen M. Cefoperazone sodium in the treatment of serious infections in 2,100 adults and children; multicentered trials in Europe, Latin America, and Australia. Rev Infect Dis 1983; 5 (Suppl) : S188-S199.
2. Barillari A, Devriendt E, Cieters P, et al. Open multicenter study of cefoperazone in the treatment of severe infections in the pediatric age group. Curr Ther Res 1987; 41:57-64.
3. Lee JS, Kim DH, Chin DS, et al. Clinical study of cefoperazone in the treatment of bacterial infection in the practice of pediatrics. New Med J (Korea) 1985; 28 : 65-76.
4. Kobayashi Y, Morikawa, Y, Haruta T, Fujiwara T. Clinical evaluation of cefoperazone in children. Jpn J Antibiot 1980; 33 : 910-915.
5. Matsuda H, Yoshida T, Kagata N, Niino S. Clinical examination of cefoperazone in pediatrics. Jpn J Antibiot 1980; 33 : 935-940.
6. Motohiro T, Sakata Y; Fujimoto T; et al. Treatment of whooping cough and whooping cough syndrome by cefoperazone (author's trans). Jpn J Antibiot 1980; 33 : 1183-1193.
7. Pape JW, Gerdes H, Orioll. Typhoid fever; Successful therapy with cefoperazone. J Infect Dis 1986; 153 : 272-276.
8. Soe GB, Overturf GD. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins. Rev Infect Dis 1987; 9 : 719-736.
9. Neu HC. A review and summary of the pharmacokinetics of cefoperazone; a new, extended-spectrum β-lactam antibiotic. Ther Drug Monitoring 1981; 3 : 121-128.
10. Chandrasekar PH. Bacterial infections in hospitalized patients. Ind J Int Med 1995; 5 (suppl 5) : 3-11.
11. Saito A, Ueda Yasushi. Multicenter clinical trials of cefoperazone in Japan. Clinical Therapeutics 1984; 7 (1) : 49-59.
12. The cefoperazone collaborative post-marketing surveillance study group. Cefoperazone : Results of a post-marketing surveillance study in patients and correlation of in vitro susceptibility tests with clinical outcome. Hasp Today 1997; 2(5) : 21-30.
13. Cristiano P, Pempinello R, lovene MR, Coppola L, Altucci P. Cefoperazone therapy of bacterial meningits; a clinical trial. Infection 1989; 17 (6) : 378-81.
14. Kitamura K, Shimizu T, Abe H, et al. Clinical studies of cefoperazone in neurosurgery. Jpn J Antibiot 1986; 39 (1) : 63-74.
15. Ueda Y. Clinical and bacteriological efficacy of cefoperazone sodium in worldwide studies of 4,485 adults and paediatric patients. International Medicine 1983; 2 (3) : 15-20.
16. Murray PR. Antimicrobial susceptibility tests; Testing methods and interpretative problems. In : Poupard JA. Walsh AR, Kleger B, eds. Antimicrobial susceptibility testing : Critical issues for the 90s. Advances in Experimental Medicine and Biology, Vol 349, New York : Plenum Press, 1994; 15-25.